 | • レポートコード：MRC2-11QY02545 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病治療薬のグローバル市場について調査・分析したレポートです。種類別（1型糖尿病、2型糖尿病、その他）市場規模、用途別（病院用、診療所用、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病治療薬の競争状況、市場シェア ・世界の糖尿病治療薬市場：種類別市場規模 2015年-2020年（1型糖尿病、2型糖尿病、その他） ・世界の糖尿病治療薬市場：種類別市場規模予測 2021年-2026年（1型糖尿病、2型糖尿病、その他） ・世界の糖尿病治療薬市場：用途別市場規模 2015年-2020年（病院用、診療所用、家庭用、その他） ・世界の糖尿病治療薬市場：用途別市場規模予測 2021年-2026年（病院用、診療所用、家庭用、その他） ・北米の糖尿病治療薬市場分析：米国、カナダ ・ヨーロッパの糖尿病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi-Aventis、Takeda Pharmaceuticals、Eli Lilly、Oramed Pharmaceuticals、Boehringer Ingelheim、Merck & Co. Inc.、Novo Nordisk、Bristol-Myers Squibb、Halozyme Therapeutics、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.
The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.
Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.
Market Analysis and Insights: Global Antidiabetics Market
The global Antidiabetics market size is projected to reach US$ 61740 million by 2026, from US$ 58180 million in 2020, at a CAGR of 5.7%% during 2021-2026.
Global Antidiabetics Scope and Market Size
Antidiabetics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antidiabetics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antidiabetics market is segmented into
Type 1 Diabetes
Type 2 Diabetes
Other
Segment by Application, the Antidiabetics market is segmented into
Hospital Use
Clinic Use
Household
Other
Regional and Country-level Analysis
The Antidiabetics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antidiabetics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antidiabetics Market Share Analysis
Antidiabetics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antidiabetics business, the date to enter into the Antidiabetics market, Antidiabetics product introduction, recent developments, etc.
The major vendors covered:
Sanofi-Aventis
Takeda Pharmaceuticals
Eli Lilly
Oramed Pharmaceuticals
Boehringer Ingelheim
Merck & Co. Inc.
Novo Nordisk
Bristol-Myers Squibb
Halozyme Therapeutics
Pfizer
1 Study Coverage
1.1 Antidiabetics Product Introduction
1.2 Market Segments
1.3 Key Antidiabetics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antidiabetics Market Size Growth Rate by Type
1.4.2 Type 1 Diabetes
1.4.3 Type 2 Diabetes
1.4.4 Other
1.5 Market by Application
1.5.1 Global Antidiabetics Market Size Growth Rate by Application
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Household
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antidiabetics Market Size, Estimates and Forecasts
2.1.1 Global Antidiabetics Revenue 2015-2026
2.1.2 Global Antidiabetics Sales 2015-2026
2.2 Global Antidiabetics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antidiabetics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antidiabetics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antidiabetics Competitor Landscape by Players
3.1 Antidiabetics Sales by Manufacturers
3.1.1 Antidiabetics Sales by Manufacturers (2015-2020)
3.1.2 Antidiabetics Sales Market Share by Manufacturers (2015-2020)
3.2 Antidiabetics Revenue by Manufacturers
3.2.1 Antidiabetics Revenue by Manufacturers (2015-2020)
3.2.2 Antidiabetics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antidiabetics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antidiabetics Revenue in 2019
3.2.5 Global Antidiabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antidiabetics Price by Manufacturers
3.4 Antidiabetics Manufacturing Base Distribution, Product Types
3.4.1 Antidiabetics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antidiabetics Product Type
3.4.3 Date of International Manufacturers Enter into Antidiabetics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antidiabetics Market Size by Type (2015-2020)
4.1.1 Global Antidiabetics Sales by Type (2015-2020)
4.1.2 Global Antidiabetics Revenue by Type (2015-2020)
4.1.3 Antidiabetics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antidiabetics Market Size Forecast by Type (2021-2026)
4.2.1 Global Antidiabetics Sales Forecast by Type (2021-2026)
4.2.2 Global Antidiabetics Revenue Forecast by Type (2021-2026)
4.2.3 Antidiabetics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antidiabetics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antidiabetics Market Size by Application (2015-2020)
5.1.1 Global Antidiabetics Sales by Application (2015-2020)
5.1.2 Global Antidiabetics Revenue by Application (2015-2020)
5.1.3 Antidiabetics Price by Application (2015-2020)
5.2 Antidiabetics Market Size Forecast by Application (2021-2026)
5.2.1 Global Antidiabetics Sales Forecast by Application (2021-2026)
5.2.2 Global Antidiabetics Revenue Forecast by Application (2021-2026)
5.2.3 Global Antidiabetics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antidiabetics by Country
6.1.1 North America Antidiabetics Sales by Country
6.1.2 North America Antidiabetics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antidiabetics Market Facts & Figures by Type
6.3 North America Antidiabetics Market Facts & Figures by Application
7 Europe
7.1 Europe Antidiabetics by Country
7.1.1 Europe Antidiabetics Sales by Country
7.1.2 Europe Antidiabetics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antidiabetics Market Facts & Figures by Type
7.3 Europe Antidiabetics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antidiabetics by Region
8.1.1 Asia Pacific Antidiabetics Sales by Region
8.1.2 Asia Pacific Antidiabetics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antidiabetics Market Facts & Figures by Type
8.3 Asia Pacific Antidiabetics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antidiabetics by Country
9.1.1 Latin America Antidiabetics Sales by Country
9.1.2 Latin America Antidiabetics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antidiabetics Market Facts & Figures by Type
9.3 Central & South America Antidiabetics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antidiabetics by Country
10.1.1 Middle East and Africa Antidiabetics Sales by Country
10.1.2 Middle East and Africa Antidiabetics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antidiabetics Market Facts & Figures by Type
10.3 Middle East and Africa Antidiabetics Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Corporation Information
11.1.2 Sanofi-Aventis Description and Business Overview
11.1.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi-Aventis Antidiabetics Products Offered
11.1.5 Sanofi-Aventis Related Developments
11.2 Takeda Pharmaceuticals
11.2.1 Takeda Pharmaceuticals Corporation Information
11.2.2 Takeda Pharmaceuticals Description and Business Overview
11.2.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Takeda Pharmaceuticals Antidiabetics Products Offered
11.2.5 Takeda Pharmaceuticals Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Antidiabetics Products Offered
11.3.5 Eli Lilly Related Developments
11.4 Oramed Pharmaceuticals
11.4.1 Oramed Pharmaceuticals Corporation Information
11.4.2 Oramed Pharmaceuticals Description and Business Overview
11.4.3 Oramed Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Oramed Pharmaceuticals Antidiabetics Products Offered
11.4.5 Oramed Pharmaceuticals Related Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Description and Business Overview
11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Ingelheim Antidiabetics Products Offered
11.5.5 Boehringer Ingelheim Related Developments
11.6 Merck & Co. Inc.
11.6.1 Merck & Co. Inc. Corporation Information
11.6.2 Merck & Co. Inc. Description and Business Overview
11.6.3 Merck & Co. Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck & Co. Inc. Antidiabetics Products Offered
11.6.5 Merck & Co. Inc. Related Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Corporation Information
11.7.2 Novo Nordisk Description and Business Overview
11.7.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novo Nordisk Antidiabetics Products Offered
11.7.5 Novo Nordisk Related Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Corporation Information
11.8.2 Bristol-Myers Squibb Description and Business Overview
11.8.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bristol-Myers Squibb Antidiabetics Products Offered
11.8.5 Bristol-Myers Squibb Related Developments
11.9 Halozyme Therapeutics
11.9.1 Halozyme Therapeutics Corporation Information
11.9.2 Halozyme Therapeutics Description and Business Overview
11.9.3 Halozyme Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Halozyme Therapeutics Antidiabetics Products Offered
11.9.5 Halozyme Therapeutics Related Developments
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Description and Business Overview
11.10.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfizer Antidiabetics Products Offered
11.10.5 Pfizer Related Developments
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Corporation Information
11.1.2 Sanofi-Aventis Description and Business Overview
11.1.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi-Aventis Antidiabetics Products Offered
11.1.5 Sanofi-Aventis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antidiabetics Market Estimates and Projections by Region
12.1.1 Global Antidiabetics Sales Forecast by Regions 2021-2026
12.1.2 Global Antidiabetics Revenue Forecast by Regions 2021-2026
12.2 North America Antidiabetics Market Size Forecast (2021-2026)
12.2.1 North America: Antidiabetics Sales Forecast (2021-2026)
12.2.2 North America: Antidiabetics Revenue Forecast (2021-2026)
12.2.3 North America: Antidiabetics Market Size Forecast by Country (2021-2026)
12.3 Europe Antidiabetics Market Size Forecast (2021-2026)
12.3.1 Europe: Antidiabetics Sales Forecast (2021-2026)
12.3.2 Europe: Antidiabetics Revenue Forecast (2021-2026)
12.3.3 Europe: Antidiabetics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antidiabetics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antidiabetics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antidiabetics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antidiabetics Market Size Forecast by Region (2021-2026)
12.5 Latin America Antidiabetics Market Size Forecast (2021-2026)
12.5.1 Latin America: Antidiabetics Sales Forecast (2021-2026)
12.5.2 Latin America: Antidiabetics Revenue Forecast (2021-2026)
12.5.3 Latin America: Antidiabetics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antidiabetics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antidiabetics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antidiabetics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antidiabetics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antidiabetics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antidiabetics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antidiabetics Market Segments
Table 2. Ranking of Global Top Antidiabetics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antidiabetics Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Type 1 Diabetes
Table 5. Major Manufacturers of Type 2 Diabetes
Table 6. Major Manufacturers of Other
Table 7. Global Antidiabetics Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Antidiabetics Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Antidiabetics Sales by Regions 2015-2020 (K Units)
Table 10. Global Antidiabetics Sales Market Share by Regions (2015-2020)
Table 11. Global Antidiabetics Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Antidiabetics Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Antidiabetics Sales Share by Manufacturers (2015-2020)
Table 14. Global Antidiabetics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Antidiabetics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidiabetics as of 2019)
Table 16. Antidiabetics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Antidiabetics Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Antidiabetics Price (2015-2020) (USD/Unit)
Table 19. Antidiabetics Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Antidiabetics Product Type
Table 21. Date of International Manufacturers Enter into Antidiabetics Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Antidiabetics Sales by Type (2015-2020) (K Units)
Table 24. Global Antidiabetics Sales Share by Type (2015-2020)
Table 25. Global Antidiabetics Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Antidiabetics Revenue Share by Type (2015-2020)
Table 27. Antidiabetics Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Antidiabetics Sales by Application (2015-2020) (K Units)
Table 29. Global Antidiabetics Sales Share by Application (2015-2020)
Table 30. North America Antidiabetics Sales by Country (2015-2020) (K Units)
Table 31. North America Antidiabetics Sales Market Share by Country (2015-2020)
Table 32. North America Antidiabetics Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Antidiabetics Revenue Market Share by Country (2015-2020)
Table 34. North America Antidiabetics Sales by Type (2015-2020) (K Units)
Table 35. North America Antidiabetics Sales Market Share by Type (2015-2020)
Table 36. North America Antidiabetics Sales by Application (2015-2020) (K Units)
Table 37. North America Antidiabetics Sales Market Share by Application (2015-2020)
Table 38. Europe Antidiabetics Sales by Country (2015-2020) (K Units)
Table 39. Europe Antidiabetics Sales Market Share by Country (2015-2020)
Table 40. Europe Antidiabetics Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Antidiabetics Revenue Market Share by Country (2015-2020)
Table 42. Europe Antidiabetics Sales by Type (2015-2020) (K Units)
Table 43. Europe Antidiabetics Sales Market Share by Type (2015-2020)
Table 44. Europe Antidiabetics Sales by Application (2015-2020) (K Units)
Table 45. Europe Antidiabetics Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Antidiabetics Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Antidiabetics Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Antidiabetics Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Antidiabetics Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Antidiabetics Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Antidiabetics Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Antidiabetics Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Antidiabetics Sales Market Share by Application (2015-2020)
Table 54. Latin America Antidiabetics Sales by Country (2015-2020) (K Units)
Table 55. Latin America Antidiabetics Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Antidiabetics Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Antidiabetics Revenue Market Share by Country (2015-2020)
Table 58. Latin America Antidiabetics Sales by Type (2015-2020) (K Units)
Table 59. Latin America Antidiabetics Sales Market Share by Type (2015-2020)
Table 60. Latin America Antidiabetics Sales by Application (2015-2020) (K Units)
Table 61. Latin America Antidiabetics Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Antidiabetics Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Antidiabetics Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Antidiabetics Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Antidiabetics Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Antidiabetics Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Antidiabetics Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Antidiabetics Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Antidiabetics Sales Market Share by Application (2015-2020)
Table 70. Sanofi-Aventis Corporation Information
Table 71. Sanofi-Aventis Description and Major Businesses
Table 72. Sanofi-Aventis Antidiabetics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Sanofi-Aventis Product
Table 74. Sanofi-Aventis Recent Development
Table 75. Takeda Pharmaceuticals Corporation Information
Table 76. Takeda Pharmaceuticals Description and Major Businesses
Table 77. Takeda Pharmaceuticals Antidiabetics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Takeda Pharmaceuticals Product
Table 79. Takeda Pharmaceuticals Recent Development
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Major Businesses
Table 82. Eli Lilly Antidiabetics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Eli Lilly Product
Table 84. Eli Lilly Recent Development
Table 85. Oramed Pharmaceuticals Corporation Information
Table 86. Oramed Pharmaceuticals Description and Major Businesses
Table 87. Oramed Pharmaceuticals Antidiabetics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Oramed Pharmaceuticals Product
Table 89. Oramed Pharmaceuticals Recent Development
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Major Businesses
Table 92. Boehringer Ingelheim Antidiabetics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Product
Table 94. Boehringer Ingelheim Recent Development
Table 95. Merck & Co. Inc. Corporation Information
Table 96. Merck & Co. Inc. Description and Major Businesses
Table 97. Merck & Co. Inc. Antidiabetics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merck & Co. Inc. Product
Table 99. Merck & Co. Inc. Recent Development
Table 100. Novo Nordisk Corporation Information
Table 101. Novo Nordisk Description and Major Businesses
Table 102. Novo Nordisk Antidiabetics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Novo Nordisk Product
Table 104. Novo Nordisk Recent Development
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Major Businesses
Table 107. Bristol-Myers Squibb Antidiabetics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Bristol-Myers Squibb Product
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Halozyme Therapeutics Corporation Information
Table 111. Halozyme Therapeutics Description and Major Businesses
Table 112. Halozyme Therapeutics Antidiabetics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Halozyme Therapeutics Product
Table 114. Halozyme Therapeutics Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Major Businesses
Table 117. Pfizer Antidiabetics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Pfizer Product
Table 119. Pfizer Recent Development
Table 120. Global Antidiabetics Sales Forecast by Regions (2021-2026) (K Units)
Table 121. Global Antidiabetics Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Antidiabetics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Antidiabetics Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Antidiabetics Sales Forecast by Country (2021-2026) (K Units)
Table 125. North America: Antidiabetics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Antidiabetics Sales Forecast by Country (2021-2026) (K Units)
Table 127. Europe: Antidiabetics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Antidiabetics Sales Forecast by Region (2021-2026) (K Units)
Table 129. Asia Pacific: Antidiabetics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Antidiabetics Sales Forecast by Country (2021-2026) (K Units)
Table 131. Latin America: Antidiabetics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Antidiabetics Sales Forecast by Country (2021-2026) (K Units)
Table 133. Middle East and Africa: Antidiabetics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Antidiabetics Players
Table 138. Antidiabetics Customers List
Table 139. Antidiabetics Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Antidiabetics Product Picture
Figure 2. Global Antidiabetics Sales Market Share by Type in 2020 & 2026
Figure 3. Type 1 Diabetes Product Picture
Figure 4. Type 2 Diabetes Product Picture
Figure 5. Other Product Picture
Figure 6. Global Antidiabetics Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Use
Figure 8. Clinic Use
Figure 9. Household
Figure 10. Other
Figure 11. Antidiabetics Report Years Considered
Figure 12. Global Antidiabetics Market Size 2015-2026 (US$ Million)
Figure 13. Global Antidiabetics Sales 2015-2026 (K Units)
Figure 14. Global Antidiabetics Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Antidiabetics Sales Market Share by Region (2015-2020)
Figure 16. Global Antidiabetics Sales Market Share by Region in 2019
Figure 17. Global Antidiabetics Revenue Market Share by Region (2015-2020)
Figure 18. Global Antidiabetics Revenue Market Share by Region in 2019
Figure 19. Global Antidiabetics Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Antidiabetics Revenue in 2019
Figure 21. Antidiabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Antidiabetics Sales Market Share by Type (2015-2020)
Figure 23. Global Antidiabetics Sales Market Share by Type in 2019
Figure 24. Global Antidiabetics Revenue Market Share by Type (2015-2020)
Figure 25. Global Antidiabetics Revenue Market Share by Type in 2019
Figure 26. Global Antidiabetics Market Share by Price Range (2015-2020)
Figure 27. Global Antidiabetics Sales Market Share by Application (2015-2020)
Figure 28. Global Antidiabetics Sales Market Share by Application in 2019
Figure 29. Global Antidiabetics Revenue Market Share by Application (2015-2020)
Figure 30. Global Antidiabetics Revenue Market Share by Application in 2019
Figure 31. North America Antidiabetics Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Antidiabetics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Antidiabetics Sales Market Share by Country in 2019
Figure 34. North America Antidiabetics Revenue Market Share by Country in 2019
Figure 35. U.S. Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Antidiabetics Market Share by Type in 2019
Figure 40. North America Antidiabetics Market Share by Application in 2019
Figure 41. Europe Antidiabetics Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Antidiabetics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Antidiabetics Sales Market Share by Country in 2019
Figure 44. Europe Antidiabetics Revenue Market Share by Country in 2019
Figure 45. Germany Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Antidiabetics Market Share by Type in 2019
Figure 56. Europe Antidiabetics Market Share by Application in 2019
Figure 57. Asia Pacific Antidiabetics Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Antidiabetics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Antidiabetics Sales Market Share by Region in 2019
Figure 60. Asia Pacific Antidiabetics Revenue Market Share by Region in 2019
Figure 61. China Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Antidiabetics Market Share by Type in 2019
Figure 84. Asia Pacific Antidiabetics Market Share by Application in 2019
Figure 85. Latin America Antidiabetics Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Antidiabetics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Antidiabetics Sales Market Share by Country in 2019
Figure 88. Latin America Antidiabetics Revenue Market Share by Country in 2019
Figure 89. Mexico Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Antidiabetics Market Share by Type in 2019
Figure 96. Latin America Antidiabetics Market Share by Application in 2019
Figure 97. Middle East and Africa Antidiabetics Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Antidiabetics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Antidiabetics Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Antidiabetics Revenue Market Share by Country in 2019
Figure 101. Turkey Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Antidiabetics Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Antidiabetics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Antidiabetics Market Share by Type in 2019
Figure 108. Middle East and Africa Antidiabetics Market Share by Application in 2019
Figure 109. North America Antidiabetics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Antidiabetics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Antidiabetics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Antidiabetics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Antidiabetics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Antidiabetics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Antidiabetics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Antidiabetics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Antidiabetics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Antidiabetics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
糖尿病治療の世界市場（～2026年） Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved people's living habits, disease control effect, is becoming m…- 不適切管理2型糖尿病治療の世界市場（～2026年） Diabetes is a serious complex condition which can affect the entire body. Diabetes occurs due to inadequate secretion of insulin inside the pancreas. Insulin secreted by pancreas in hormone made by beta cell which is responsible for the conversion of glucose from food to energy. There are different …
- 糖尿病モニターの世界市場（～2026年） Diabetes mellitus is a chronic disease resulting from an inadequacy of insulin in the body. The condition causes either elevated blood-glucose concentrations, named as hyperglycaemia, or low glucose level known as hypoglycaemia. Monitoring glucose level is expected to prolong life expectancy as it e…
- 糖尿病治療装置・薬剤の世界市場（～2026年） Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs. The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet. Market Analysis an…
- 1型糖尿病の世界市場（～2026年） Type 1 diabetes is a form of diabetes mellitus in which very little or no insulin is produced by the pancreas. The global type 1 diabetes market is expected to grow modestly during the forecast period owing to growing incidence and prevalence of diabetes and cohesive government policies. Market Anal…